@article{a72f2fb1c7014c20a4f162c5705cc4ed,
title = "Cost-effectiveness of abatacept, tocilizumab and TNF-inhibitors compared with rituximab as second-line biologic drug in rheumatoid arthritis",
keywords = "MODIFYING ANTIRHEUMATIC DRUGS, NECROSIS-FACTOR INHIBITOR, COLLEGE-OF-RHEUMATOLOGY, EULAR RECOMMENDATIONS, MANAGEMENT, FAILURE, VALIDATION, SAFETY, LIFE, 3121 General medicine, internal medicine and other clinical medicine, 317 Pharmacy",
author = "Saara Huoponen and Aaltonen, {Kalle J.} and Jaana Viikinkoski and Jarno Rutanen and Heikki Relas and Kirsi Taimen and Kari Puolakka and Dan Nordstr{\"o}m and Marja Blom",
year = "2019",
month = jul,
day = "24",
doi = "10.1371/journal.pone.0220142",
language = "English",
volume = "14",
journal = "PLoS One",
issn = "1932-6203",
publisher = "PUBLIC LIBRARY OF SCIENCE",
number = "7",
}